TRIM25: A Global Player of Cell Death Pathways and Promising Target of Tumor-Sensitizing Therapies
Therapy resistance still constitutes a common hurdle in the treatment of many human cancers and is a major reason for treatment failure and patient relapse, concomitantly with a dismal prognosis. In addition to “intrinsic resistance”, e.g., acquired by random mutations, cancer cells typically escape...
Saved in:
Main Authors: | Wolfgang Eberhardt, Usman Nasrullah, Josef Pfeilschifter |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/14/2/65 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Impacts of Trimming Mangroves
by: Natalia Medina Irizarry, et al.
Published: (2022-02-01) -
The critical role of TRIM protein family in intervertebral disc degeneration: mechanistic insights and therapeutic perspectives
by: Shangze Li, et al.
Published: (2025-02-01) -
Advances in non-apoptotic regulated cell death: implications for malignant tumor treatment
by: Yizheng Zhang, et al.
Published: (2025-01-01) -
The PB1 protein of H9N2 influenza A virus inhibits antiviral innate immunity by targeting MAVS for TRIM25-mediated autophagic degradationThe parent data and images support the findings of this work freely available at
by: Jiawei Luo, et al.
Published: (2025-01-01) -
Emerging Roles of TRIM56 in Antiviral Innate Immunity
by: Dang Wang, et al.
Published: (2025-01-01)